Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Traphaco is a leading pharmaceutical company in Vietnam, recognized as a pioneer in the development of high-quality herbal medicines and phytopharmaceuticals. Founded in 1972, the company has built a dominant market position through its "Green Health" strategy, which integrates sustainable herbal cultivation with modern manufacturing technologies. Its flagship products, including Boganic for liver health and Cebraton for brain circulation, are household names in the Vietnamese domestic market. Traphaco operates multiple GMP-WHO certified facilities and maintains an extensive distribution network across the country. The company is currently expanding its portfolio into modern western medicines and nutritional supplements through strategic partnerships and technology transfers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Traphaco.